Skip to main content
Erschienen in: Pathology & Oncology Research 4/2016

10.03.2016 | Original Article

Trends in Gastrointestinal Cancer Mortality Rate in Hungary

verfasst von: Klaudia Farkas, Mónika Szűcs, Tibor András Nyári

Erschienen in: Pathology & Oncology Research | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to investigate the annual death trends for gastrointestinal cancer in Hungary between 1963 and 2012. Data on the numbers of cancer deaths were obtained from the published nationwide population register. Numbers of deaths from esophageal, gastric and colorectal cancer were available during the study period. However, the mortality data for hepatic, pancreatic and gallbladder cancer have been published only since 1979. Joinpoint regression was applied to investigate the annual trends in the rates of cancer mortality. The annual mortality rates of gastric and gallbladder cancer decreased throughout the study period. Furthermore, declines in mortality from esophageal and hepatic cancers have been observed since 1998 and 1995, respectively. However, the rates of colorectal and pancreatic cancer mortality have been increasing in the past few years. Nevertheless, the mortality rates of colorectal and pancreatic cancers have increased in males aged 40–59 years during the study period. Moreover, significantly higher risks of gastrointestinal cancer-related deaths have been observed in males as compared with females except for death related to cancer of the gallbladder. The presented data suggest that the Hungarian mortality rates are particularly high. The detection of gastrointestinal cancers at an early stage would significantly improves the outcome of these malignancies.
Literatur
1.
Zurück zum Zitat Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. (2015) Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385(9972):977–1010CrossRefPubMed Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. (2015) Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385(9972):977–1010CrossRefPubMed
2.
Zurück zum Zitat The Hungarian Central Statistical Office. Demographic Yearbook (1963-2012) Budapest. KSH 2013 The Hungarian Central Statistical Office. Demographic Yearbook (1963-2012) Budapest. KSH 2013
3.
Zurück zum Zitat Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403CrossRefPubMed Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403CrossRefPubMed
4.
Zurück zum Zitat Bosetti C, Bertuccio P, Malvezzi M, Levi F, Chatenoud L, Negri E, La Vecchia C (2013) Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol 24:2657–2671CrossRefPubMed Bosetti C, Bertuccio P, Malvezzi M, Levi F, Chatenoud L, Negri E, La Vecchia C (2013) Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol 24:2657–2671CrossRefPubMed
5.
Zurück zum Zitat Jemal A, Center MM, DeSantis C, Ward EM (2010) Global Patterns of Cancer Incidence and Mortality Rates and Trends. Cancer Epidemiol Biomark Prev 19:1893–1907CrossRef Jemal A, Center MM, DeSantis C, Ward EM (2010) Global Patterns of Cancer Incidence and Mortality Rates and Trends. Cancer Epidemiol Biomark Prev 19:1893–1907CrossRef
6.
Zurück zum Zitat Szabolcs O (2003) Cancer epidemiology in Hungary and the Béla Johan National Program for the decade of health. Pathol Oncol Res 9:126–130CrossRefPubMed Szabolcs O (2003) Cancer epidemiology in Hungary and the Béla Johan National Program for the decade of health. Pathol Oncol Res 9:126–130CrossRefPubMed
7.
Zurück zum Zitat Péter A (2013) Connection between cancer- and alcohol-related mortality in a rural practice of a South-Hungarian village. Orv Hetil 154:700–706CrossRefPubMed Péter A (2013) Connection between cancer- and alcohol-related mortality in a rural practice of a South-Hungarian village. Orv Hetil 154:700–706CrossRefPubMed
8.
Zurück zum Zitat Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335–351CrossRefPubMed Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335–351CrossRefPubMed
9.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed
10.
Zurück zum Zitat Spallek J, Arnold M, Razum O, Juel K, Rey G, Deboosere P, Mackenbach JP, Kunst AE (2012) Cancer mortality patterns among Turkish immigrants in four European countries and in Turkey. Eur J Epidemiol 27:915–921CrossRefPubMed Spallek J, Arnold M, Razum O, Juel K, Rey G, Deboosere P, Mackenbach JP, Kunst AE (2012) Cancer mortality patterns among Turkish immigrants in four European countries and in Turkey. Eur J Epidemiol 27:915–921CrossRefPubMed
11.
Zurück zum Zitat Randi G, Franceschi S, La Vecchia C (2006) Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 118:1591–1602CrossRefPubMed Randi G, Franceschi S, La Vecchia C (2006) Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 118:1591–1602CrossRefPubMed
12.
Zurück zum Zitat Levi F, Lucchini F, Negri E, La Vecchia C (2004) Trends in Mortality from Major Cancers in The European Union, Including Acceding Countries, in 2004. Cancer 101:2843–2850CrossRefPubMed Levi F, Lucchini F, Negri E, La Vecchia C (2004) Trends in Mortality from Major Cancers in The European Union, Including Acceding Countries, in 2004. Cancer 101:2843–2850CrossRefPubMed
13.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefPubMed
14.
Zurück zum Zitat Bosetti C, Levi F, Rosato V, Bertuccio P, Lucchini F, Negri E, La Vecchia C (2011) Recent trends in colorectal cancer mortality in Europe. Int J Cancer 129:180–191CrossRefPubMed Bosetti C, Levi F, Rosato V, Bertuccio P, Lucchini F, Negri E, La Vecchia C (2011) Recent trends in colorectal cancer mortality in Europe. Int J Cancer 129:180–191CrossRefPubMed
15.
Zurück zum Zitat Sunkara V (2015) Hébert JR. The colorectal cancer mortality-to-incidence ratio as an indicator of global cancer screening and care Cancer 121:1563–1569PubMed Sunkara V (2015) Hébert JR. The colorectal cancer mortality-to-incidence ratio as an indicator of global cancer screening and care Cancer 121:1563–1569PubMed
16.
Zurück zum Zitat Ll H, Tulassay Z (2010) Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 14:249–258 Ll H, Tulassay Z (2010) Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 14:249–258
17.
Zurück zum Zitat Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, Negri E, La Vecchia C, Lunet N (2014) Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype. Eur J Cancer 50:1330–1344CrossRefPubMed Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, Negri E, La Vecchia C, Lunet N (2014) Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype. Eur J Cancer 50:1330–1344CrossRefPubMed
18.
Zurück zum Zitat de Vries E, Arroyave I, Pardo C, Wiesner C, Murillo R, Forman D, Burdorf A, Avendaño M (2015) Trends in inequalities in premature cancer mortality by educational level in Colombia, 1998-2007. J Epidemiol Community Health 69:408–415CrossRefPubMed de Vries E, Arroyave I, Pardo C, Wiesner C, Murillo R, Forman D, Burdorf A, Avendaño M (2015) Trends in inequalities in premature cancer mortality by educational level in Colombia, 1998-2007. J Epidemiol Community Health 69:408–415CrossRefPubMed
19.
Zurück zum Zitat Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F (2014) Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomark Prev 23:700–713CrossRef Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F (2014) Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomark Prev 23:700–713CrossRef
20.
Zurück zum Zitat AEl S, RA D'A Jr, RA B, DC S (2003) International variation in pancreatic cancer mortality for the period 1955-1998. Eur J Epidemiol 18:801–816 AEl S, RA D'A Jr, RA B, DC S (2003) International variation in pancreatic cancer mortality for the period 1955-1998. Eur J Epidemiol 18:801–816
21.
Zurück zum Zitat AAl B, LJ S, Volovics A, Dorant E, Den Brandt PA v (2000) Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 29:645–654CrossRef AAl B, LJ S, Volovics A, Dorant E, Den Brandt PA v (2000) Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 29:645–654CrossRef
22.
Zurück zum Zitat Kroep S, Lansdorp-Vogelaar I, Rubenstein JH, Lemmens VE, van Heijningen EB, Aragonés N, van Ballegooijen M, Inadomi JM (2014) Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands. Am J Gastroenterol 109:336–343 quiz 335, 344CrossRefPubMed Kroep S, Lansdorp-Vogelaar I, Rubenstein JH, Lemmens VE, van Heijningen EB, Aragonés N, van Ballegooijen M, Inadomi JM (2014) Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands. Am J Gastroenterol 109:336–343 quiz 335, 344CrossRefPubMed
23.
Zurück zum Zitat Cl C, Bosetti C, Malvezzi M, Bertuccio P, Levi F, Negri E, La Vecchia C, Lunet N (2014) Patterns and trends in esophageal cancer mortality and incidence in Europe (1980–2011) and predictions to 2015. Ann Oncol 25:283–290CrossRef Cl C, Bosetti C, Malvezzi M, Bertuccio P, Levi F, Negri E, La Vecchia C, Lunet N (2014) Patterns and trends in esophageal cancer mortality and incidence in Europe (1980–2011) and predictions to 2015. Ann Oncol 25:283–290CrossRef
24.
Zurück zum Zitat Bjerregaard JK, Mortensen MB, Pfeiffer P, Academy of Geriatric Cancer Research (AgeCare) (2016) Trends in cancer of the liver, gall bladder, bile duct, and pancreas in elderly in Denmark, 1980–2012. Acta Oncol 55(Suppl 1):40–45CrossRefPubMed Bjerregaard JK, Mortensen MB, Pfeiffer P, Academy of Geriatric Cancer Research (AgeCare) (2016) Trends in cancer of the liver, gall bladder, bile duct, and pancreas in elderly in Denmark, 1980–2012. Acta Oncol 55(Suppl 1):40–45CrossRefPubMed
25.
Zurück zum Zitat Bosch FX, Ribes J, Díaz M, Cléries R (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127(5 Suppl 1):S5–S16 ReviewCrossRefPubMed Bosch FX, Ribes J, Díaz M, Cléries R (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127(5 Suppl 1):S5–S16 ReviewCrossRefPubMed
26.
Zurück zum Zitat Center MM, Jemal A (2011) International trends in liver cancer incidence rates. Cancer Epidemiol Biomark Prev 20:2362–2368CrossRef Center MM, Jemal A (2011) International trends in liver cancer incidence rates. Cancer Epidemiol Biomark Prev 20:2362–2368CrossRef
27.
Zurück zum Zitat Döbrőssy L, Kovács A, Budai A, Simon J, Horváth AR, Cornides A, Tulassay Z (2011) Controversial issues in colorectal screening in Hungary: conflict of clinical and public health viewpoints. Orv Hetil 152:1223–1232CrossRefPubMed Döbrőssy L, Kovács A, Budai A, Simon J, Horváth AR, Cornides A, Tulassay Z (2011) Controversial issues in colorectal screening in Hungary: conflict of clinical and public health viewpoints. Orv Hetil 152:1223–1232CrossRefPubMed
Metadaten
Titel
Trends in Gastrointestinal Cancer Mortality Rate in Hungary
verfasst von
Klaudia Farkas
Mónika Szűcs
Tibor András Nyári
Publikationsdatum
10.03.2016
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 4/2016
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-016-0052-y

Weitere Artikel der Ausgabe 4/2016

Pathology & Oncology Research 4/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.